Palomar (NASDAQ:PLMR) Insider Sells $30,998.16 in Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) insider Timothy Carter sold 254 shares of the business’s stock in a transaction that occurred on Thursday, January 29th. The stock was sold at an average price of $122.04, for a total value of $30,998.16. Following the sale, the insider directly owned 1,300 shares in the company, valued at $158,652. The trade was a 16.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Timothy Carter also recently made the following trade(s):

• On Thursday, January 29th, Timothy Carter sold 254 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total value of $30,998.16.

Palomar Price Performance

Shares of Palomar stock traded up $0.63 on Monday, reaching $124.22. The company had a trading volume of 240,836 shares, compared to its average volume of 180,129. The firm has a market cap of $3.29 billion, a price-to-earnings ratio of 19.38 and a beta of 0.44. The firm’s 50-day moving average price is $127.67 and its two-hundred day moving average price is $123.57. Palomar Holdings, Inc. has a 1 year low of $104.47 and a 1 year high of $175.85.

Palomar (NASDAQ:PLMR) last issued its quarterly earnings results on Thursday, November 6th. The company reported $2.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.45. The company had revenue of $244.66 million during the quarter, compared to the consensus estimate of $207.98 million. Palomar had a return on equity of 21.93% and a net margin of 22.59%.During the same period last year, the company earned $1.23 earnings per share. As a group, analysts anticipate that Palomar Holdings, Inc. will post 5.99 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Keefe, Bruyette & Woods upped their price target on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a report on Tuesday, January 6th. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Wall Street Zen upgraded Palomar from a “hold” rating to a “buy” rating in a report on Saturday, January 10th. Finally, JPMorgan Chase & Co. lifted their target price on Palomar from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 7th. Six analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Palomar presently has an average rating of “Moderate Buy” and a consensus target price of $159.50.

More Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Palomar closed the acquisition of The Gray Casualty & Surety Company, expanding its surety capabilities and product mix — a strategic tuck?in that can add premium, diversify risk exposure and support growth in specialty lines. BCP Completes Sale of The Gray Casualty & Surety Company
• Neutral Sentiment: Palomar will report Q4 and full?year 2025 results after the close on Feb 11, 2026, with a conference call Feb 12 — an event that typically drives short?term volume and volatility as investors update estimates and listen for management commentary on reserve development, underwriting margin, and growth. Earnings Release & Conference Call
• Negative Sentiment: Multiple insiders (including the CEO, President, CFO and other senior executives) sold shares on Jan. 29 and Jan. 31, reducing positions by low-single-digit percentages in many cases. Heavy insider selling can signal liquidity taking or tax/comp planning, but it may concern some investors about insider confidence or timing ahead of earnings. Representative coverage of recent insider sales is here. CEO Sells Stock (Example)

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Osaic Holdings Inc. grew its stake in Palomar by 93.7% during the 2nd quarter. Osaic Holdings Inc. now owns 19,370 shares of the company’s stock worth $2,933,000 after buying an additional 9,371 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new stake in Palomar in the third quarter worth about $1,459,000. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Palomar by 11.1% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 456,172 shares of the company’s stock worth $53,258,000 after acquiring an additional 45,665 shares during the last quarter. Y Intercept Hong Kong Ltd grew its stake in shares of Palomar by 434.6% during the third quarter. Y Intercept Hong Kong Ltd now owns 36,496 shares of the company’s stock worth $4,261,000 after acquiring an additional 29,669 shares during the last quarter. Finally, Hussman Strategic Advisors Inc. acquired a new position in shares of Palomar during the third quarter valued at about $2,452,000. Institutional investors own 90.25% of the company’s stock.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.